Showing results (81-90 of 90) with videos related to
Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Acta Neuropsychiatrica|April 12, 2024
Impact of elevated body mass index (BMI) on cognitive functioning and inflammation in persons with post-COVID-19 condition: a secondary analysisGia Han Le, Angela T H Kwan, Ziji Guo, et al.Brain : a Journal of Neurology|November 8, 2023
Vortioxetine for the treatment of post-COVID-19 condition: a randomized controlled trialRoger S McIntyre, Lee Phan, Angela T H Kwan, et al.Brain, Behavior, and Immunity|January 1, 2022
Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysisFelicia Ceban, Susan Ling, Leanna M W Lui, et al.CNS Drugs|August 7, 2021
Prevention and Management of Common Adverse Effects of Ketamine and Esketamine in Patients with Mood DisordersFelicia Ceban, Joshua D Rosenblat, Kevin Kratiuk, et al.Journal of Affective Disorders|July 16, 2020
The effectiveness of repeated intravenous ketamine on depressive symptoms, suicidal ideation and functional disability in adults with major depressive disorder and bipolar disorder: Results from the Canadian Rapid Treatment Center of ExcellenceRoger S McIntyre, Nelson B Rodrigues, Yena Lee, et al.Clinical Nursing Research|April 15, 2025
Impact of Fatigue on Subjective and Objective Cognitive Functions in Persons with Post-COVID-19 ConditionGia Han Le, Angela T H Kwan, Ziji Guo, et al.Journal of Affective Disorders|August 21, 2024
Association between cognitive functioning, suicidal ideation and suicide attempts in major depressive disorder, bipolar disorder, schizophrenia and related disorders: A systematic review and meta-analysisGia Han Le, Sabrina Wong, Sipan Haikazian, et al.Journal of Affective Disorders|September 3, 2020
The effect of intravenous, intranasal, and oral ketamine in mood disorders: A meta-analysisRoger S McIntyre, Isabelle P Carvalho, Leanna M W Lui, et al.Expert Opinion on Pharmacotherapy|January 2, 2024
The efficacy of zuranolone in postpartum depression and major depressive disorder: a review & number needed to treat (NNT) analysisDanielle S Cha, Nicholas Kleine, Kayla M Teopiz, et al.Bulletin of the World Health Organization|November 12, 2020
Development and implementation of guidelines for the management of depression: a systematic reviewYena Lee, Elisa Brietzke, Bing Cao, et al.Pageof 9